Sunitinib
Study 1
Pfizer · Phase 3 · Completed · Enrollment 361
| Arm | Reported safety |
|---|---|
| Sunitinib 50 mg, 4 weeks on 2 off | n/r |
| Placebo | n/r |
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Sunitinib
Pfizer · Phase 3 · Completed · Enrollment 361
| Arm | Reported safety |
|---|---|
| Sunitinib 50 mg, 4 weeks on 2 off | n/r |
| Placebo | n/r |
A count stays a count. This page does not turn a count into a percent.